• Search
  • Login
  • Register
Menu
  • BJMO
  • Home
  • News
  • CongressUpdate
  • Specials
  • Links
All
  • All
  • BJMO articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > ELCC 2022

Category

ELCC 2022
  • Health of Tomorrow
  • Healthy Living
  • Corona
  • Medical Research
  • Therapy

ELCC 2022

Sintilimab plus pemetrexed and platinum as first-line treatment for locally advanced or metast...

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • Immunotherapy: a game changer for patients with extensive stage small cell lung cancer
  • ESMO develops new, living guidelines for the treatment of patients with metastatic non-small cell lung cancer
  • Targeted therapy and immunotherapy in early-stage non-small cell lung cancer
  • Antibody-drug conjugates in lung cancer: a paradigm shift on the horizon?
ELCC 2022

Osimertinib as neoadjuvant treatment for resectable stage II-IIIB EGFR-mutated lung adenocarci...

Read more
ELCC 2022

Savolitinib in the treatment of patients with non-small cell lung cancer and MET exon 14 skipp...

Read more
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJMO
  • Ads & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJMO is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJMO 2023